Insmed Incorporated (INSM) Financial Statements
Insmed Incorporated (INSM) reported trailing twelve-month revenue of $1.1B (up 185.8% year on year) and net income of -$875.3M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$807.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
INSMInsmed IncorporatedFollow INSM — free
—
Price chart with a free account
- Market cap
- 20.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2013 Dec 13 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.01 | 0.01 | 0.14 | 0.16 | 0.19 | 0.25 | 0.31 | 0.36 | 0.61 | 1.14 | |
| Gross profit | — | — | 0.01 | 0.11 | 0.12 | 0.14 | 0.19 | 0.24 | 0.28 | 0.48 | 0.95 | |
| Research & development | 0.03 | 0.04 | 0.15 | 0.13 | 0.18 | 0.27 | 0.40 | 0.57 | 0.60 | 0.77 | 0.86 | |
| Operating income | -0.06 | -0.06 | -0.31 | -0.24 | -0.27 | -0.38 | -0.46 | -0.71 | -0.88 | -1.25 | -0.84 | |
| Pre-tax income | -0.06 | -0.06 | -0.32 | -0.25 | -0.29 | -0.44 | -0.48 | -0.75 | -0.91 | -1.27 | -0.87 | |
| Income tax | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Net income | -0.06 | -0.06 | -0.32 | -0.25 | -0.29 | -0.43 | -0.48 | -0.75 | -0.91 | -1.28 | -0.88 | |
| Diluted EPS ($) | -2.95 | -1.60 | -4.22 | -3.01 | -3.01 | -3.88 | -3.91 | -5.34 | -5.57 | -6.42 | -4.10 | |
| Diluted shares (bn) | 0.023 | 0.035 | 0.077 | 0.085 | 0.098 | 0.112 | 0.123 | 0.140 | 0.164 | 0.199 | — |
USD billions · SEC XBRL
Insmed Incorporated — questions
- What is Insmed Incorporated's revenue?
- $1.1B over the twelve months to 2026-06-30, up 185.8% year on year, from its 10-Q and 10-K filings.
- What is Insmed Incorporated's net income?
- -$875.3M over the twelve months to 2026-06-30.
- What is Insmed Incorporated's free cash flow?
- -$807.7M over the twelve months to 2026-06-30.
- What are Insmed Incorporated's diluted earnings per share?
- $-4.10 over the twelve months to 2026-06-30.
Every figure on this page comes from Insmed Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.